Programming the EPIcardium to CURE broken hearts

EPICURE aims to decode human epicardial development and regeneration using pluripotent stem cell-derived epicardioids, enhancing insights for cardiac repair through advanced imaging and CRISPR techniques.

Subsidie
€ 2.499.999
2024

Projectdetails

Introduction

Cardiac diseases are the leading cause of death worldwide, making human cardiac regeneration one of the most critical unmet clinical needs. The epicardium, the mesothelial envelope of the heart, is the source of several cardiac cells and provides signals that are essential for myocardial growth and vessel formation during development.

Research Background

Extensive animal research has indicated that the reactivation of these embryonic epicardial programs is the key to adult tissue repair in regenerative species such as the zebrafish, as well as in rodents up until a few days after birth, before the heart’s capacity for regeneration is lost. However, how the human epicardium develops and responds to injury is largely unknown.

Recent Developments

We recently established the first human pluripotent stem cell-based cardiac organoids showing the self-organization of epicardium and myocardium into a functionally patterned structure resembling the embryonic ventricular wall. These ‘epicardioids’ offer unique possibilities to study the dynamics of human epicardium development and function at a single-cell resolution.

Project Goals

EPICURE aims at decoding and harnessing these programs as potentially transformative means for human heart regeneration. The following methodologies will be employed:

  1. State-of-the-art lineage recordings
  2. 3D imaging
  3. Spatial multiomics in epicardioids

These techniques will be used to dissect the fate acquisition mechanisms of the human embryonic epicardium and identify critical signalling pathways in health and disease.

Complementary Approaches

This in vitro approach will be complemented by charting a spatiotemporal, cross-species single-cell atlas of the cardiac injury response ex vivo and in vivo, including the first genetic lineage tracing of the adult epicardium in a large animal model.

Innovative Concepts

Finally, we will capitalize on the novel concept that CRISPR-mediated, temporal programming of the epicardium could drive meaningful heart regeneration in adulthood.

Conclusion

Clearly, EPICURE will yield a wealth of new insights into human epicardial biology while breaking new ground in cardiac regenerative medicine.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.499.999
Totale projectbegroting€ 2.499.999

Tijdlijn

Startdatum1-7-2024
Einddatum30-6-2029
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHENpenvoerder

Land(en)

Germany

Vergelijkbare projecten binnen European Research Council

ERC Starting...

Harnessing Novel Micropeptides in Cardiomyocytes to promote Cardiac Regeneration

Novel.CaRe aims to enhance cardiac regeneration post-myocardial infarction by using micropeptides to stimulate cardiomyocyte proliferation and maturation through innovative gene therapy approaches.

€ 1.592.281
ERC Advanced...

The transcriptional regulation of cardiomyocyte polyploidization and its relevance in cardiac regeneration

REACTIVA aims to promote heart regeneration by reactivating adult diploid cardiomyocytes through a newly identified regulatory network and inhibiting a specific transcription factor.

€ 2.500.000
ERC Consolid...

Mechanisms and consequences of cell state transitions during heart regeneration

This project aims to uncover the coordinated cellular responses in zebrafish heart regeneration post-injury using single-cell genomics and computational methods to enhance understanding of organ repair mechanisms.

€ 2.000.000
ERC Advanced...

Advanced human models of the heart to understand cardiovascular disease

Heart2Beat aims to develop innovative 3D human cardiac models using microfluidic technology to enhance understanding and treatment of cardiovascular diseases through personalized medicine.

€ 2.500.000
ERC Starting...

Unraveling pacemaker (dys)function using novel stem cell-derived human heart models

This project aims to enhance understanding of sinoatrial node function and its dysfunction in heart rhythm disorders using innovative in vitro models derived from human pluripotent stem cells.

€ 1.797.105

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

Engineering a living human Mini-heart and a swimming Bio-robot

The project aims to develop advanced in vitro human cardiac models, including a vascularized mini-heart and a bio-robot, to better assess cardiotoxicity and improve understanding of cardiovascular disease.

€ 4.475.946
EIC Transition

Bringing 3D cardiac tissues to high throughput for drug discovery screens

Developing a high-throughput 3D cardiac model using microfluidic technology to enhance drug discovery for cardiovascular disease by improving predictive accuracy and scalability.

€ 1.457.500